妊娠期的癌症，在妊娠期间被诊断出的癌症，是一种罕见但严重的疾病，面临临床和伦理方面的挑战。在过去的两十年里，发生了一种范式转变，推荐开始胎儿第一期之后，在妊娠和非妊娠癌症患者中采用类似的分期和治疗方案。这种策略是在越来越多有关妊娠期化疗治疗的令人放心的报告出现之后形成的。妊娠期癌症的管理应由多学科团队进行，其中包括分期、肿瘤治疗、社会和心理护理、分娩时机和婴儿的随访计划。由于罕见的情况，建议进行中心化管理以积累经验。此外，在缺乏专业知识时，国家和国际咨询委员会提供支持。 © 2023 The Authors. 由John Wiley & Sons Ltd代表北欧产科和妇科学会（Nordic Federation of Societies of Obstetrics and Gynecology，简称NFOG）发表的《Acta Obstetricia et Gynecologica Scandinavica》

Cancer in pregnancy, defined as a cancer diagnosed during pregnancy, is a rare but severe condition presenting both clinical and ethical challenges. During the last two decades a paradigm shift has occurred towards recommending similar staging and treatment regimens of pregnant and non-pregnant cancer patients. This strategy is a result of an increasing number of reassuring reports on chemotherapy treatment in pregnancy after the first trimester. The management of cancer in pregnancy should be managed in a multidisciplinary team where staging, oncological treatment, social and mental care, timing of delivery, and follow-up of the infant should be planned. Due to the rarity, centralization is recommended to allow experience accumulation. Furthermore, national and international advisory boards are supportive when there is a lack of expertise.© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).